Pemetrexed + cisplatin (DDP) in patients with malignant peritoneal mesothelioma (AbM)

Systemic Chemotherapy with Pemetrexed and Cisplatin for Malignant Peritoneal Mesothelioma: A Single Institution Experience

“…The discrepancy may encompass the fact that the Expanded Access Program study collectively reports the results on chemotherapy naïve patients treated with pemetrexed alone or in combination with cisplatin 18 . Nevertheless, the results reported in the Open Label German trial did not significantly differ from our findings, as the former reported objective response in 36% of patients (5/6 vs 4/11; P = 0.131, Fisher's exact test) 23 .…”